The company is awaiting Competition Commission of India (CCI) approval for the rights issue.
PharmEasy CEO hopes to return to market with an IPO if robust performance sustains on December 15, 2023 at 9:33 am
The company is awaiting Competition Commission of India (CCI) approval for the rights issue.